Moreover, the PDE/cGMP/PKG axis is essential for maintaining the stemness of PC3-derived cancer stem cells, and combining PDE5 inhibitors with chemotherapeutics effectively impedes prostate cancer progression and metastasis (Table 1) (51). The gene discussed is PDE5A; the disease is prostate cancer.